Eric Falcand
Directeur Général chez Neopharmed Gentili SpA
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Alessandro del Bono | M | - |
Neopharmed Gentili SpA
 Neopharmed Gentili SpA Pharmaceuticals: MajorHealth Technology Neopharmed Gentili SpA is a holding company, which engages in the production and sale of pharmaceutical products. the firm includes development and marketing of therapeutic solutions in vascular, cardio-metabolic, respiratory, antibiotic, and over-the-counter medications. Its products include drugs, medical devices, food supplements, and cosmetics. The company was founded in 2009 and is headquartered in Milan, Italy. | - |
| Jean-Christophe Tellier | M | 65 |
Servier Laboratories
 Servier Laboratories Pharmaceuticals: MajorHealth Technology Servier Laboratories operates as a French pharmaceutical company. The private company is based in Paris, France and has subsidiaries in Belgium. | - |
| Laurent Perret | M | - |
Servier Laboratories
Servier Laboratories Pharmaceuticals: MajorHealth Technology Servier Laboratories operates as a French pharmaceutical company. The private company is based in Paris, France and has subsidiaries in Belgium. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Marc Ladreit de Lacharrière | M | 83 |
Synthélabo SA
 Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | 5 ans |
| Eliseo Salinas | M | 69 |
Synthélabo SA
Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | 2 ans |
| Jean-Pierre Charlet | M | 71 |
Synthélabo SA
Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | 3 ans |
| Jean Michel Demeure | M | 62 |
Synthélabo SA
Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | 8 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| France | 6 | 85,71% |
| Italie | 1 | 14,29% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Eric Falcand
- Réseau Personnel
